Clinical Trial: Pharmacological Intervention to Prevent NOAF After TAVR

U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT07519161) titled 'Pharmacological Intervention to Prevent NOAF After TAVR' on April 01.

Brief Summary: The goal of this clinical trial is to learn if amiodarone or metoprolol works to prevent new-onset atrial fibrillation (AF) in patients who develop certain atrial arrhythmias after transcatheter aortic valve replacement (TAVR). It will also learn about the safety of these drugs. The main questions it aims to answer are:

* Do amiodarone or metoprolol reduce the incidence of new-onset AF within 90 days after TAVR?

* What medical problems do participants have when taking amiodarone or metoprolol?

Researchers will compare amiodarone and metoprolol t...